אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - metronidazole benzoate, quantity: 64 mg/ml - oral liquid, suspension - excipient ingredients: ethanol; monobasic sodium phosphate; aluminium magnesium silicate; methyl hydroxybenzoate; sucrose; propyl hydroxybenzoate; orange oil terpeneless; flavour - anaerobic infections treatment of infections in which anaerobic bacteria have been identified or are suspected as pathogens, particularly bacteroides fragilis and other species of bacteroides, and other species such as fusobacteria, eubacteria, clostridia and anaerobic streptococci. flagyl has been used successfully in septicaemia; bacteraemia; brain abscess; necrotising pneumonia; osteomyelitis; puerperal sepsis; pelvic abscess; pelvic cellulitis; postoperative wound infections. notes. 1. because of the slow absorption and delayed peak plasma level, flagyl suspension is not recommended for use in the acute situation. 2. metronidazole is inactive against aerobic and facultative anaerobic bacteria. other indications oral treatment of urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male, and for the treatment of bacterial vaginosis. the male consort of females suffering from urogenital trichomoniasis should be treated concurrently; all forms of amoebiasis( intestinal and extraintestin

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - metronidazole; metronidazole benzoate -

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - metronidazole - infusion - 5mg/1ml

ישראל - אנגלית - Ministry of Health

sanofi israel ltd - metronidazole - film coated tablets - metronidazole 250 mg - metronidazole - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria, lambliasis.

ישראל - אנגלית - Ministry of Health

sanofi israel ltd - metronidazole as benzoate - suspension - metronidazole as benzoate 25 mg/ml - metronidazole - metronidazole - infections caused by anaerobic bacterias, amebiosis, lambliasis and trichomonas.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - metronidazole -

קניה - אנגלית - Pharmacy and Poisons Board

sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - metronidazole - solution for infusion - 500mg/100ml - antibacterials for systemic use: imidazole

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - metronidazole 1000mg - suppository - 1000 mg - active: metronidazole 1000mg excipient: hard fat

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - metronidazole 500mg - suppository - 500 mg - active: metronidazole 500mg excipient: hard fat

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - metronidazole benzoate 64 mg/ml equivalent to 40 mg/ml metronidazole.;  ;   - oral suspension - 200 mg/5ml - active: metronidazole benzoate 64 mg/ml equivalent to 40 mg/ml metronidazole.     excipient: aluminium magnesium silicate citrus limon ethanol methyl hydroxybenzoate monobasic sodium phosphate dihydrate propyl hydroxybenzoate purified water sucrose liquid terpeneless orange oil